GB Pharma S.r.l. – Trademark Portfolio
Entity Type: 16
GB Pharma S.r.l. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TECRENZIA.
Via Leonardo Da Vinci 43
I-20090 Trezzano Sul Naviglio (MI)
Showing of trademarks Trademarks
Trademark Classifications
GB Pharma S.r.l.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does GB Pharma S.r.l. have?
GB Pharma S.r.l. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does GB Pharma S.r.l. file in?
GB Pharma S.r.l. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GB Pharma S.r.l.'s most well-known trademarks?
GB Pharma S.r.l.'s registered trademark portfolio includes well-known marks such as TECRENZIA. These are among 1 currently registered trademark in the portfolio.
What is GB Pharma S.r.l.'s trademark registration success rate?
GB Pharma S.r.l. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.